Latest p/e ratio
Alnylam Pharmaceuticals P/E ratio
Direct answer
Alnylam Pharmaceuticals's p/e ratio is 38.91x.
The verified market snapshot reports 38.91x.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- P/E ratio
- 38.91x
Explore related company data
View Alnylam Pharmaceuticals's market capitalizationView Alnylam Pharmaceuticals's price-to-book ratioView Alnylam Pharmaceuticals's return on equityView Alnylam Pharmaceuticals's dividend yieldView Alnylam Pharmaceuticals's 52-week price rangeView Alnylam Pharmaceuticals's revenue growthView Alnylam Pharmaceuticals's profit marginView Alnylam Pharmaceuticals's debt-to-equity ratioView all Alnylam Pharmaceuticals key metricsReturn to Alnylam Pharmaceuticals profile